--- title: "\"Performance\" DAWNRAYS PHARMA's mid-term net profit is 105 million RMB, down 78.8%, with a dividend of 1.5 HK cents" description: "DAWNRAYS PHARMA announced its interim results for the six months ended June, with revenue of RMB 630 million, a year-on-year decrease of 9.2%. It recorded a net profit of RMB 105 million, a decline of" type: "news" locale: "en" url: "https://longbridge.com/en/news/254325767.md" published_at: "2025-08-24T13:37:43.000Z" --- # "Performance" DAWNRAYS PHARMA's mid-term net profit is 105 million RMB, down 78.8%, with a dividend of 1.5 HK cents > DAWNRAYS PHARMA announced its interim results for the six months ended June, with revenue of RMB 630 million, a year-on-year decrease of 9.2%. It recorded a net profit of RMB 105 million, a decline of 78.8%, with earnings per share of 6.961 cents. The interim dividend remains at 1.5 HK cents DAWNRAYS PHARMA (02348.HK) announced its interim results for the six months ending in June, with revenue of RMB 630 million, a year-on-year decrease of 9.2%. It recorded a net profit of RMB 105 million, a decline of 78.8%, with earnings per share of 6.961 cents. The interim dividend remains at 1.5 Hong Kong cents ### Related Stocks - [02348.HK - DAWNRAYS PHARMA](https://longbridge.com/en/quote/02348.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 瑞银:预计 2026 年人形机器人需求 3 万台,真正放量或在 2027—2028 年 | 瑞银报告指出,人形机器人正加速从概念验证迈向工业应用,2026 年全球需求量预计达 3 万台,若 AI 技术突破或客户反馈积极,乐观情境下可达 4 万台。2025 年全球出货约 1.86 万台,中国企业宇树科技与智元机器人合计出货近万台,占 | [Link](https://longbridge.com/en/news/275780289.md) | | 市场监管总局约谈阿里巴巴、抖音、百度、腾讯、京东、美团、淘宝闪购等平台企业 | 市场监管总局于 2 月 13 日约谈了阿里巴巴、抖音、百度、腾讯、京东、美团和淘宝闪购等平台企业,要求它们遵守相关法律法规,落实主体责任,规范促销行为,并杜绝 “内卷式” 竞争,以维护公平竞争市场环境,促进平台经济的创新与健康发展。 | [Link](https://longbridge.com/en/news/275975190.md) | | 股价还能再涨 55%!英国对冲基金押注:全球最大马桶制造商 TOTO 将是 AI 芯片隐形赢家 | 马桶巨头变身 AI 概念股!激进投资者 Palliser 盯上日本 TOTO,称其为” 最被低估的 AI 受益者”。这家卫浴制造商凭陶瓷技术掌握半导体核心设备静电卡盘,贡献 40% 运营利润,股价一年已涨超 60%。Palliser 测算仍 | [Link](https://longbridge.com/en/news/276110046.md) | | 一场由减肥 “神药” 引发的 “甜味危机”:糖价腰斩,连梦龙也卖不动了! | GLP-1 类减肥药正通过改变饮食行为,重塑糖与蛋白质的需求结构,并迅速传导至期货与股票市场。纽约原糖期货跌破 14 美分,创 2020 年以来新低,较 2023 年末高点腰斩。全球最大冰淇淋公司梦龙在销量不及预期后股价大跌,引发对冰淇淋等 | [Link](https://longbridge.com/en/news/275766631.md) | | 硕腾|10-K:2025 财年营收 94.67 亿美元超过预期 | | [Link](https://longbridge.com/en/news/275813665.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.